Lantus is a long-acting insulin that was first approved by the FDA in 2000. It is typically used to treat type 2 diabetes and is taken once daily. Lantus is manufactured by Sanofi-Aventis and its generic name is insulin glargine.
Toujeo is a long-acting insulin that was approved by the FDA in 2015. It is a newer insulin that is very similar to Lantus, another long-acting insulin. Toujeo is a once-daily insulin that is given by injection. It is designed to provide a steady level of insulin throughout the day and night.
- Lantus is a long-acting insulin that can help control blood sugar levels in people with diabetes.
- It is taken once daily, and it can help to keep blood sugar levels under control for up to 24 hours.
- It can be used alone or in combination with other diabetes medications.
- Lantus has been shown to lower A1C levels, which is a measure of long-term blood sugar control.
- It can also help to reduce the risk of complications from diabetes, such as heart disease and stroke.
- Lantus is generally well-tolerated, with the most common side effects being mild hypoglycemia and injection site reactions.
- It is available in both vials and prefilled pens, so it can be easily administered at home or on the go.
- Toujeo is a long-acting insulin that can help control blood sugar for up to 36 hours.
- Toujeo is designed to provide a steady, consistent level of insulin throughout the day and night.
- Toujeo can help reduce the risk of low blood sugar (hypoglycemia) when used alone or in combination with other diabetes medications.
- Toujeo may also help improve A1C levels, which is a measure of your average blood sugar over time.
Lantus Vs Toujeo Dosing Comparison
Lantus is the winner because it has a more consistent effect and lasts longer.